VEEV Form 144: 6,000-share sale via Morgan Stanley, $1.84M value

Rhea-AI Filing Summary

Veeva Systems Inc. filed a Form 144 reporting a proposed sale of 6,000 common shares through Morgan Stanley Smith Barney LLC on the 10/07/2025. The filing states the aggregate market value of the shares is $1,839,693.60 and lists 163,908,013 shares outstanding, indicating the sale is a small fraction of outstanding stock. The securities were acquired the same day by stock option exercise and paid for in cash. The filer certifies there is no undisclosed material adverse information and reports no related sales in the prior three months.

Positive

• None.

Negative

• Proposed sale of 6,000 shares valued at $1,839,693.60 by an insider
• No trading plan adoption date disclosed though the filing references Rule 10b5-1 representations

Insights

Securities Counsel

TL;DR: Routine Rule 144 notice for an option exercise sale, with standard certifications.

The filing documents a proposed Rule 144 sale of 6,000 shares acquired by stock option exercise and paid in cash on 10/07/2025

Compliance risks center on the filer’s representation that no material non-public information exists and on timing relative to any trading plans; the form references the Rule 10b5-1 trading-plan representation but does not disclose a plan adoption date.

Equity Capital Markets Analyst

TL;DR: Insider sale of 6,000 shares valued at $1.84M is reported; size appears limited relative to total shares outstanding.

The filing shows an aggregate market value of $1,839,693.60 for the proposed sale and lists 163,908,013 shares outstanding, which frames the sale as a small-scale disposition. There are no reported sales by the filer in the prior three months.

Watch for any subsequent Form 4 filings that confirm execution or additional insider transactions within the next few trading days.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	6000	1839693.60	163908013	10/07/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/07/2025	Stock Option Exercise	Issuer			6000	10/07/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did VEEV report in the Form 144 filing?

The filing reports a proposed Rule 144 sale of 6,000 common shares through Morgan Stanley Smith Barney LLC with aggregate market value $1,839,693.60 and an approximate sale date of 10/07/2025.

How were the shares acquired for the VEEV Form 144 sale?

The shares were acquired on 10/07/2025 by stock option exercise from the issuer, and payment was in cash on the same date.

Does the filing show prior sales by the filer in the last three months?

No. The filing states "Nothing to Report" for securities sold during the past three months.

Which broker is handling the proposed VEEV sale?

The broker named is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.

What certification does the filer make on the Form 144?

By signing, the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed and references Rule 10b5-1 plan representation if applicable.